GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Auxly Cannabis Group XLY.TO · CAD

Health Care · Toronto Stock Exchange · 🇨🇦 Canada

Compare

3.49

-3.32%

Close of 9 Nov 2026, in CAD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CAD, from our data supplier.

FY2024

Revenue

C$122.3m

FY2015FY2024

Net income

−C$16.3m

FY2015FY2024

Free cash flow

C$14.0m

FY2015FY2024

Shareholders' equity

C$115.7m

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
RevenueC$122.3mC$101.1mC$94.5mC$83.8mC$50.8mC$8.4mC$747,000C$1.4mC$231,233C$257,208
Research and development———————C$8.4m——
Operating incomeC$8.3m−C$23.4m−C$76.8m−C$41.3m−C$47.1m−C$62.6m−C$50.6m−C$16.6m−C$359,406C$40,821
Net income−C$16.3m−C$44.5m−C$130.3m−C$33.7m−C$85.4m−C$102.6m−C$67.0m−C$18.2m−C$229,577C$32,547
Diluted earnings per share-0.01-0.04-0.15-0.06-1.67-2.30-1.60-0.70-0.060.05

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Total assetsC$261.5mC$261.9mC$331.8mC$450.4mC$379.0mC$411.6mC$460.8mC$92.6mC$416,945C$721,734
Cash and short-term investmentsC$18.5mC$15.8mC$14.8mC$14.9m——————
Total liabilitiesC$145.9mC$210.9mC$241.4mC$237.9mC$187.4mC$149.7mC$139.7mC$29.8mC$32,958C$27,057
DebtC$68.5mC$159.0mC$193.6mC$190.1mC$110.5mC$90.9mC$94.2mC$18.7m——
Shareholders' equityC$115.7mC$51.0mC$90.4mC$212.5mC$195.9mC$264.3mC$318.1mC$62.8mC$383,987C$694,677
Shares outstanding1,205m991m890m783m51m45m42m26m4m1m

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015
Cash from operationsC$16.8mC$8.2m−C$2.5m−C$49.6m−C$33.1m−C$79.1m−C$43.7m−C$11.4m−C$359,335C$32,599
Capital spending−C$2.8m−C$1.6m−C$9.2m−C$380,000−C$20.7m−C$37.8m−C$17.5m−C$687,000−C$687,000−C$687,000
Free cash flowC$14.0mC$6.6m−C$11.7m−C$50.0m−C$53.9m−C$116.9m−C$61.2m−C$12.1m−C$1.0m−C$654,401

Latest quarters

By quarter end

Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023
RevenueC$39.9mC$38.8mC$32.7mC$34.6mC$33.3mC$29.2mC$25.2mC$26.9m
Operating incomeC$8.0mC$7.4mC$3.2mC$6.6m−C$3.8m−C$4.0m−C$5.1m−C$11.3m
Net incomeC$20.5mC$8.3mC$12.1mC$4.4mC$3.2mC$2.0m−C$26.0m−C$54.0m
Diluted earnings per share0.010.010.010.000.000.00-0.03-0.05
Total assetsC$276.4mC$258.5mC$264.8mC$261.5mC$264.2mC$260.6mC$260.1mC$261.9m
Cash and short-term investmentsC$30.6mC$17.2mC$17.3mC$18.5mC$19.1mC$14.4mC$13.2mC$15.8m
DebtC$51.0mC$13.0mC$13.7mC$14.5mC$53.2mC$56.6mC$53.4mC$93.9m
Shareholders' equityC$172.5mC$137.4mC$128.3mC$115.7mC$111.5mC$106.3mC$104.1mC$51.0m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue13.4%71.1%84.0%
Operating income——68.0%
Net income-21.5%-30.7%—

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-6.8%-33.2%-52.7%-66.9%
Net margin-27.2%-56.0%-89.6%-107.4%

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Price to earnings-41.3-3.1-1.0-30.1-1.1-1.6-4.0
Price to sales5.51.41.312.11.820.2357.7

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 3-for-1 split · 10 Apr 2017

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.